Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor) Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor)

Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor‪)‬

Clinical Chemistry 2000, Dec, 46, 12

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

To the Editor: We wish to report a serious problem in the ADVIA:Centaur[R] chemiluminescence assay for cobalamin (Bayer Diagnostics; formerly the ACS:Centaur[R] assay, Chiron Diagnostics). The problem is urgent for two reasons: (a) our findings suggest that many cobalamin-deficient patients are being missed; and (b) the assay is used by increasing numbers of laboratories, which some time ago abandoned radioisotopic methods and were recently faced with the withdrawal of widely used assays by Abbott Laboratories.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2000
1. Dezember
SPRACHE
EN
Englisch
UMFANG
9
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
GRÖSSE
165,3
 kB

Mehr ähnliche Bücher

Bias and Random Error in Retinol Measurements of Laboratories in Countries with Populations with Mild to Severe Vitamin A Deficiency (Technical Briefs) Bias and Random Error in Retinol Measurements of Laboratories in Countries with Populations with Mild to Severe Vitamin A Deficiency (Technical Briefs)
2002
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Why We Don't Know the Answer May Be More Important Than the Specific Question (Editorials) (Clinical Report) Why We Don't Know the Answer May Be More Important Than the Specific Question (Editorials) (Clinical Report)
2004
Contemporary Practice in Clinical Chemistry (Enhanced Edition) Contemporary Practice in Clinical Chemistry (Enhanced Edition)
2020
The Quality of Clinical Trials with Harpagophytum Procumbens (Review) The Quality of Clinical Trials with Harpagophytum Procumbens (Review)
2003
Statistical Issues in Drug Research and Development Statistical Issues in Drug Research and Development
2017

Mehr Bücher von Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998